Paradigm Biocapital Advisors LP TARS Holdings History
Paradigm Biocapital Advisors LP's Tarsus Pharmaceuticals Inc Holding Summary
As of 2025-03-31, Paradigm Biocapital Advisors LP held 2.61 Mil shares of Tarsus Pharmaceuticals Inc(TARS), totaling $134.09 Mil. This investment constitutes 6.14% of their stock portfolio, and Paradigm Biocapital Advisors LP now holds 6.21% of the outstanding Tarsus Pharmaceuticals Inc(TARS) stock.
The initial trade took place in 2023Q4. And since then Paradigm Biocapital Advisors LP has made 5 purchases of TARS, at an average price of $26.12, for a total of 3.04 Mil shares. In addition, there have been 1 sales at an average price of $33.62 for 427,990.00 shares. Based on historical transaction data and TARS's current price of $43.25, Paradigm Biocapital Advisors LP's estimated gain on his TARS holdings is $47.93 Mil, reflecting a 60.40% gain to date.
Paradigm Biocapital Advisors LP TARS ($43.25) Holding Chart
Paradigm Biocapital Advisors LP TARS ($43.25) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
